Skip to search formSkip to main contentSkip to account menu

Genexol PM

Known as: Genexol-PM 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

paclitaxel-loaded polymeric micelle

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Radiolabeling Methods and Nuclear Imaging Techniques in the Design of New Polymeric Carriers for Cancer Therapy
P3-10-04: A open-label, randomized, parallel, phase III trial to evaluate the efficacy and safety of Genexol ® -PM compared to… 
2015
2015
Abstract P3-10-04: A open-label, randomized, parallel, phase III trial to evaluate the efficacy and safety of Genexol®-PM compared to Genexol®(conventional paclitaxel with cremorphor EL) in recurrent…
Background: The rationale for developing an alternative paclitaxel formulation concerns Cremophor EL-related side effects, and a… 
2014
2014
A Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast Cancer
Purpose Neoadjuvant chemotherapy (NC) is yet to be established as the definitive treatment regimen for locally advanced breast… 
2013
2013
Abstract 4659: Phase II study of a weekly liposomal paclitaxel formulation (Genexol®-PM) and gemcitabine® combination chemotherapy in patients with advanced biliary cancer.
OBJECTIVE: Advanced biliary cancer is associated with a poor prognosis due to wide resistance to chemotherapeutic agents. This… 
2011
2011
Phase II Clinical Trial of Genexol® (Paclitaxel) and Carboplatin for Patients with Advanced Non-small Cell Lung Cancer
Purpose This phase II clinical trial was conducted to evaluate the activity and safety of a combination treatment of paclitaxel… 
2010
2010
Ultrasound‐enhanced nanotherapy of pancreatic cancer
The paper reports in vivo results of ultrasonic nanotherapy of orthotopically grown pancreatic cancer. Phase‐shift paclitaxel… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)